Top 200 Pharmaceuticals by Retail Sales in 2019
Top 200 Pharmaceuticals by Retail Sales in 2019
Compiled and Produced by the Njarðarson Group (The University of Arizona)
1 k2 K3 K4 5 6 K7 K8 K9 10 11 12 13 14 15 16 17 18 19 20
(Adalimumab)
(Apixaban) (Pembrolizumab) (Lenalidomide) (Ibrutinib) (Nivolumab)
(Aflibercept) (Bevacizumab) (Etanercept) (Rivaroxaban) (Rituximab)
(Ustekinumab) (Trastuzumab) (Pneumococcal
7-Valent Conjugate)
(Infliximab) (Palbociclib) (Bictegravir, Emtricitabine,
Tenofovir Alafenamide)
(Dimethyl Fumarate) (Dulaglutide) (Enzalutamide)
$19.723
Billion $12.149 Billion $11.084 Billion $9.378 Billion $8.085 Billion
$8.015 Billion $7.363 Billion $7.285 Billion $7.216 Billion $6.81
Billion $6.671 Billion $6.594 Billion $6.22 Billion $5.847 Billion
$5.304 Billion $4.961 Billion $4.738 Billion $4.433 Billion $4.394
Billion $4.35 Billion
21 22 23 24 25 26 27 28 29 30 31 32 33 34
35 36 37 38 39 40 Lucentis Soliris Genvoya Ocrevus Botox Gardasil
Perjeta Lyrica Cosentyx Januvia
Invega Sustenna Victoza Jardiance Lantus Gilenya Neulasta Xolair Tagrisso Triumeq Entyvio
(Ranibizumab) (Eculizumab)
(Elvitegravir, Cobicistat, Emtricitabine,
Tenofovir Alafenamide)
(Ocrelizumab)
(Onabotulinumtoxin A) (HPV Quadrivalent Vaccine) (Pertuzumab)
(Pregabalin) (Secukinumab) (Sitagliptin) (Paliperidone Palmitate)
(Liraglutide) (Empagliflozin) (Insulin Glargine) (Fingolimod)
(Pegfilgrastim) (Omalizumab) (Osimertinib) (Abacavir, Dolutegravir,
Lamivudine) (Vedolizumab)
$3.967 Billion $3.946 Billion $3.931
Billion $3.819 Billion $3.791 Billion $3.737 Billion $3.628 Billion
$3.589 Billion $3.551 Billion $3.482 Billion $3.33 Billion $3.29 Billion
$3.29 Billion $3.283 Billion $3.223 Billion $3.221 Billion $3.201
Billion $3.189 Billion $3.161 Billion $3.085 Billion
Ophthalmology
Hematology Infectious Diseases CNS & Anesthesia Nephrology Vaccine
Oncology CNS & Anesthesia Immunology Diabetes CNS & Anesthesia
Diabetes Diabetes Diabetes CNS & Anesthesia Hematology Immunology
Oncology Infectious Diseases Gastrointestinal Disorders
41 42 43 44
45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Darzalex Orencia Mavyret
Humalog Truvada Zytiga Symbicort NovoRapid Prolia Sprycel Vyvanse
Actemra ProQuad Dupixent Shingrix Spiriva Xeljanz Nexium Simponi
Pomalyst
(Daratumumab) (Abatacept) (Glecaprevir/Pibrentasvir) (Insulin Lispro) (Emtricitabine, Tenofovir
Disoproxil Fumarate)
(Abiraterone
Acetate) (Budesonide, Formoterol) (Insulin Aspart) (Denosumab)
(Dasatinib) (Lisdexamfetamine) (Tocilizumab) (Measles, Mumps, Rubella,
Varicella Virus Vaccine Live)
(Dupilumab) (Zoster Vaccine Recombinant,
Adjuvanted)
(Tiotropium bromide) (Tofacitinib Citrate) (Esomeprazole) (Golimumab) (Pomalidomide)
$2.998
Billion $2.977 Billion $2.893 Billion $2.821 Billion $2.813 Billion
$2.795 Billion $2.711 Billion $2.709 Billion $2.672 Billion $2.398
Billion $2.383 Billion $2.38 Billion $2.275 Billion $2.261 Billion
$2.244 Billion $2.243 Billion $2.242 Billion $2.223 Billion $2.188
Billion $2.162 Billion
Oncology Immunology Infectious Diseases
Diabetes Infectious Diseases Oncology Respiratory Disorders Diabetes
Musculoskeletal Oncology CNS & Anesthesia Immunology Vaccine
Immunology Vaccine Respiratory Disorders Immunology Gastrointestinal
Disorders Immunology Oncology
61 62 63 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 Advair Pentacel Alimta Prezista Spinraza Lipitor
Influenza Vaccines Tivicay Aubagio Janumet Epclusa Cimzia Xgeva Tecentriq Tysabri Tasigna Velcade Prograf Latuda Aranesp
(Salmeterol)
(Vaccine) (Pemetrexed) (Darunavir, Cobicistat) (Nusinersen)
(Atorvastatin Calcium) (Vaccine) (Dolutegravir) (Teriflunomide)
(Metformin, Sitagliptin) (Sofosbuvir, Velpatasvir) (Certolizumab pegol)
(Denosumab) (Atezolizumab) (Natalizumab) (Nilotinib) (Bortezomib)
(Tacrolimus) (Lurasidone) (Darbepoetin Alfa)
$2.145 Billion $2.121
Billion $2.116 Billion $2.11 Billion $2.097 Billion $2.096 Billion
$2.061 Billion $2.061 Billion $2.048 Billion $2.041 Billion $1.965
Billion $1.953 Billion $1.935 Billion $1.931 Billion $1.892 Billion
$1.88 Billion $1.851 Billion $1.785 Billion $1.739 Billion $1.729
Billion
Respiratory Disorders Vaccine Oncology Infectious Diseases
Genetic Disorders Cardiovascular Diseases Vaccine Infectious Diseases
CNS & Anesthesia Diabetes Infectious Diseases Infectious Diseases
Oncology Oncology CNS & Anesthesia Oncology Oncology Immunology CNS
& Anesthesia Hematology
81 82 83 84 85 86 87 88 90 91 92 93 94
95 96 97 98 99 100 Entresto Jentadueto Ozempic Pradaxa Avonex Odefsey
Xyrem Lynparza Otezla Sandostatin Brilinta Crestor Farxiga Afinitor
Vimpat Copaxone Descovy Yervoy Lovenox Myrbetriq
(Sacubitril, Valsartan) (Linagliptin, Metformin
Hydrochloride)
(Semaglutide) (Dabigatran Etexilate) (Interferon Beta-1a) (Emtricitabine, Rilpivirine,
Tenofovir Alafenamide)
(Sodium
Oxybate) (Olaparib) (Apremilast) (Octreotide) (Ticagrelor)
(Rosuvastatin Calcium) (Dapagliflozin) (Everolimus) (Lacosamide)
(Glatiramer acetate) (Emtricitabine, Tenofovir
Alafenamide)
(Ipilimumab) (Enoxaparin Sodium) (Mirabegron)
$1.726
Billion $1.699 Billion $1.686 Billion $1.667 Billion $1.666 Billion
$1.655 Billion $1.643 Billion $1.642 Billion $1.607 Billion $1.585
Billion $1.581 Billion $1.565 Billion $1.543 Billion $1.539 Billion
$1.537 Billion $1.512 Billion $1.5 Billion $1.489 Billion $1.481 Billion
$1.472 Billion
Cardiovascular Diseases Diabetes Diabetes Hematology
CNS & Anesthesia Infectious Diseases CNS & Anesthesia Oncology
Dermatology Oncology Cardiovascular Diseases Cardiovascular Diseases
Diabetes Oncology CNS & Anesthesia CNS & Anesthesia Infectious
Diseases Oncology Hematology Nephrology
101 102 103 104 105 106 107
108 109 110 111 112 113 114 115 116 117 118 119 120 Imfinzi Pulmicort
Plavix Xifaxan Advate NovoMix Kadcyla Hemlibra Symdeko Promacta Forteo
Levemir Tresiba TNKase Taltz Edoxaban Abraxane Human Insulins
Tafinlar/Mekinist Synagis
(Durvalumab) (Budesonide) (Clopidogrel
Bisulfate) (Rifaximin) (Antihemophilic Factor ) (Biphasic Insulin
Aspart) (Trastuzumab Emtansine) (Emicizumab) (Tezacaftor, Ivacaftor)
(Eltrombopag Olamine/
Eltrombopag)
(Teriparatide) (Insulin
Detemir) (Insulin Degludec) (Alteplase/Tenecteplase) (Ixekizumab)
(Edoxaban) (Paclitaxel Protein Bound) (Human Insulin)
(Dabrafenib/Trametinib) (Palivizumab)
$1.469 Billion $1.466 Billion
$1.454 Billion $1.452 Billion $1.443 Billion $1.438 Billion $1.435
Billion $1.421 Billion $1.418 Billion $1.416 Billion $1.405 Billion
$1.396 Billion $1.389 Billion $1.372 Billion $1.366 Billion $1.364
Billion $1.356 Billion $1.355 Billion $1.338 Billion $1.335 Billion
Oncology
Respiratory Disorders Cardiovascular Diseases Infectious Diseases
Hematology Diabetes Oncology Hematology Genetic Disorders Oncology
Musculoskeletal Diabetes Diabetes Cardiovascular Diseases Immunology
Hematology Oncology Diabetes Oncology Respiratory Disorders
121 122
123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140
Mirena Lenvima Opsumit Galvus Humulin Gleevec Juvederm Abilify Maintena
Simponi NovoSeven Breo Ellipta Restasis Rexulti Orkambi Ventolin Esbriet
Bridion Somatuline Jakavi Basaglar
(Levonorgestrel) (Lenvatinib)
(Macitentan) (Vildagliptin) (Insulin Isophane) (Imatinib) (Hyaluronic
Acid) (Aripiprazole) (Golimumab) (Coagulation Factor VIIa
[Recombinant])
(Fluticasone
Furoate ) (Cyclosporine) (Brexpiprazole) (Lumacaftor, Ivacaftor)
(Albuterol) (Pirfenidone) (Sugammadex) (Lanreotide) (Ruxolitinib)
(Insulin Glargine )
$1.333 Billion $1.332 Billion $1.327 Billion
$1.297 Billion $1.29 Billion $1.263 Billion $1.244 Billion $1.241
Billion $1.224 Billion $1.218 Billion $1.204 Billion $1.189 Billion
$1.177 Billion $1.176 Billion $1.163 Billion $1.163 Billion $1.131
Billion $1.124 Billion $1.114 Billion $1.113 Billion
Urology Oncology
Cardiovascular Diseases Diabetes Diabetes Oncology Dermatology CNS
& Anesthesia Immunology Hematology Respiratory Disorders Immunology
CNS & Anesthesia Respiratory Disorders Respiratory Disorders
Immunology CNS & Anesthesia Oncology Oncology Diabetes
141 142
143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
Chantix Kyprolis Hepatitis Diovan Group Olmesartan Creon Exforge Tremfya
Leuprorelin Lumizyme Kalydeco Jadenu Isentress Cymbalta Toujeo Kovaltry
Acthar Nucala Norvasc Vectibix
(Varenicline) (Carfilzomib) (Vaccine)
(Hydrochlorothiazide, Valsartan) (Olmesartan) (Pancrelipase)
(Amlodipine, Valsartan) (Guselkumab) (Leuprorelin) (Alglucosidase Alfa)
(Ivacaftor) (Deferasirox) (Raltegravir) (Duloxetine) (Insulin Glargine)
(Antihemophilic Factor ) (Corticotropin) (Mepolizumab) (Amlodipine)
(Panitumumab)
$1.107 Billion $1.096 Billion $1.084 Billion $1.064
Billion $1.062 Billion $1.041 Billion $1.025 Billion $1.012 Billion
$1.005 Billion $1.001 Billion $991 Million $975 Million $975 Million
$964 Million $962 Million $961 Million $953 Million $952 Million $950
Million $948 Million
CNS & Anesthesia Oncology Vaccine
Cardiovascular Diseases Cardiovascular Diseases Rare Disorders
Cardiovascular Diseases Immunology Oncology Rare Disorders Respiratory
Disorders Oncology Infectious Diseases CNS & Anesthesia Diabetes
Rare Disorders Immunology Respiratory Disorders Cardiovascular Diseases
Oncology
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
176 177 178 179 180 Sutent Pneumovax 23 Cyramza Pediarix Alecensa
Faslodex Cialis Lupron Fabrazyme NuvaRing Adempas Epogen Edurant Vraylar
Samsca Saxenda Bexsero Keppra Linzess Uptravi
(Sunitinib Malate) (Pneumococcal Vaccine
Polyvalent)
(Ramucirumab) (Diphtheria, Pertussis,
Tetanus Acellular)
(Alectinib)
(Fulvestrant) (Tadalafil) (Leuprolide Acetate) (Agalsidase Beta)
(Ethinyl Estradiol, Etonogestrel) (Riociguat) (Epoetin Alfa)
(Rilpivirine) (Cariprazine) (Tolvaptan) (Liraglutide) (Meningococcal
Vaccine) (Levetiracetam) (Linaclotide) (Selexipag)
$936 Million $926
Million $925 Million $909 Million $902 Million $892 Million $891 Million
$887 Million $886 Million $879 Million $875 Million $867 Million $861
Million $858 Million $853 Million $852 Million $842 Million $839 Million
$827 Million $819 Million
Oncology Vaccine Oncology Vaccine Oncology
Oncology Urology Oncology Rare Disorders Women's Healthcare
Cardiovascular Diseases Hematology Infectious Diseases CNS &
Anesthesia Cardiovascular Diseases Nutritional Deficiency Vaccine CNS
& Anesthesia Gastrointestinal Disorders Cardiovascular Diseases
181
182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199
200 Zoladex Nexgard Nplate Venclexta Lixiana RotaTeq Eprex Nexplanon
Synthroid Flovent Pulmozyme Cerezyme Nexavar Benlysta Toprol-XL Votrient
Augmentin Eloctate YAZ Invokana
(Goserelin Acetate) (Afoxolaner)
(Romiplostim) (Venetoclax) (Edoxaban) (Rotavirus Vaccine) (Epoetin Alfa)
(Etonogestrel) (Levothyroxine Sodium) (Fluticasone Propionate) (Dornase
Alfa) (Imiglucerase) (Sorafenib) (Belimumab) (Metoprolol Hydrochloride)
(Pazopanib) (Amoxicillin, Clavulanate Potassium) (Antihemophilic
Factor,
Fc Fusion Protein)
(Drospirenone, Ethinyl Estradiol) (Canagliflozin, Metformin)
$813
Million $807 Million $795 Million $792 Million $791 Million $791
Million $790 Million $787 Million $786 Million $780 Million $774 Million
$772 Million $770 Million $760 Million $760 Million $755 Million $746
Million $746 Million $742 Million $735 Million
Oncology Infectious
Diseases Immunology Oncology Hematology Vaccine Hematology Women's
Healthcare Hormonal Disorders Respiratory Disorders Immunology Rare
Disorders Oncology Rare Disorders Cardiovascular Diseases Oncology
Infectious Diseases Hematology Urology Diabetes
